ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Psyence Group Inc (PK)

Psyence Group Inc (PK) (PSYGF)

0.0146
0.00
( 0.00% )
Updated: 15:17:39

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0146
Bid
0.0139
Ask
0.022
Volume
50
0.00 Day's Range 0.00
0.008 52 Week Range 0.067079
Market Cap
Previous Close
0.0146
Open
-
Last Trade
47
@
0.01795
Last Trade Time
13:41:18
Financial Volume
-
VWAP
-
Average Volume (3m)
30,405
Shares Outstanding
140,031,222
Dividend Yield
-
PE Ratio
-0.05
Earnings Per Share (EPS)
-0.2
Revenue
-
Net Profit
-27.85M

About Psyence Group Inc (PK)

Sector
Medicinal Chems,botanicl Pds
Industry
Real Estate Investment Trust
Website
Headquarters
Toronto, Ontario, Can
Founded
1994
Psyence Group Inc (PK) is listed in the Medicinal Chems,botanicl Pds sector of the OTCMarkets with ticker PSYGF. The last closing price for Psyence (PK) was $0.01. Over the last year, Psyence (PK) shares have traded in a share price range of $ 0.008 to $ 0.067079.

Psyence (PK) currently has 140,031,222 shares outstanding. The market capitalization of Psyence (PK) is $2.04 million. Psyence (PK) has a price to earnings ratio (PE ratio) of -0.05.

PSYGF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4-0.00065-4.262295081970.015250.0220.011257550.01270659CS
12-0.0081-35.68281938330.02270.02270.008304050.009471CS
26-0.0009-5.80645161290.01550.02960.008356180.01301377CS
52-0.0343-70.14314928430.04890.0670790.008400690.02369338CS
156-0.1263-89.63804116390.14090.89210.008225870.03461114CS
260-0.1892-92.83611383710.20380.89210.008219300.03470166CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AGDXFAntioqua Gold Inc (CE)
$ 0.02
(1,999,900.00%)
2.5k
ISUNQiSun Inc (CE)
$ 0.0007
(69,900.00%)
19.26k
MGTIMGT Capital Investments Inc (CE)
$ 0.0002
(19,900.00%)
125.2k
TTCFQTattooed Chef Inc (CE)
$ 0.0002
(19,900.00%)
54.74k
ECPNEl Capitan Precious Metals Inc (CE)
$ 0.0001
(9,900.00%)
2.25k
EGBBEarth Gen Biofuel Inc (CE)
$ 0.000001
(-99.95%)
8k
CNVIFConavi Medical Corporation (PK)
$ 0.0007
(-99.88%)
1.97k
BDPTDBioadaptives Inc
 0.0251
(-99.72%)
92.33k
SPRNSupernova Energy Inc (CE)
$ 0.000001
(-99.67%)
2k
FUNFFFansUnite Entertainment Inc (CE)
$ 0.000001
(-99.50%)
2.4k
GRLFGreen Leaf Innovations Inc (PK)
$ 0.0001
(0.00%)
230.2M
HCMCHealthier Choices Management Corporation (PK)
$ 0.000001
(0.00%)
130.3M
HMBLHUMBL Inc (PK)
$ 0.00025
(-16.67%)
120.83M
THBDThird Bench Inc (PK)
$ 0.0003
(200.00%)
112.63M
QEDNQED Connect Inc (PK)
$ 0.00045
(12.50%)
82.09M

PSYGF Discussion

View Posts
dirtydozen911 dirtydozen911 2 months ago
dont know why , but this P O S is up 125% at 30 mins ago scanner picked up low vol spike.
👍️0
TooFrank TooFrank 2 years ago
Colorado just legalized ‘magic mushrooms,’ an idea that’s growing nationwide

The initiative allows for the use of psilocybin at state-regulated centers under the supervision of licensed facilitators.
It also legalizes personal private use, growing and sharing of psilocybin and psilocin, as well as three additional psychedelic compounds — DMT, ibogaine and mescaline — by adults over the age of 21. Retail sales are not permitted,…

https://www.cnbc.com/amp/2022/11/12/colorado-just-legalized-magic-mushrooms-an-idea-thats-growing-nationwide.html
👍️0
TooFrank TooFrank 2 years ago
Hannam & Partners Financial Promotion of PSYGF

Psyence Group (PSYGF)
First mover into palliative care market supported
by natural psilocybin production
https://psyence.com/wp-content/uploads/2022/09/Psyence_Initiation_FINAL.02.pdf

Hannam & Partners Disclamer
https://www.hannam.partners/disclaimer/
Any Research Product is likely to be considered a financial promotion for the purposes of the FCA Rules.

Any Research Product provided by Hannam & Partners (“H&P”) will constitute “non-independent research” for the purposes of the rules from time to time of the Financial Conduct Authority (“FCA Rules”). As such it will constitute a marketing communication, has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.
👍️0
TooFrank TooFrank 2 years ago
Psyence operates one of the first and only federally licensed commercial psilocybin production facilities in the world. Is licensed to cultivate and export psilocybin mushrooms for the legal, global medical market and commercial medical research market.

Preparing to send mushrooms to Canada and Spain for analysis and extraction.

The laboratory has also been expanded to having the capability and equipment to undertake in-process testing on site, crude extraction, as well as to generate Certificates of Analysis (COAs) and undertake testing of the end product.
👍️0
TooFrank TooFrank 2 years ago
Boom in psychedelic therapies

https://www.telegraph.co.uk/news/2022/08/20/magic-mushrooms-set-become-uks-ultimate-weapon-against-depression/

👍️0